Journal of Cystic Fibrosis
Издатель: Elsevier · ISSN 1569-1993 · 83 статей
- Assessing the impact of elexacaftor/tezacaftor/ivacaftor on work productivity and activity impairment in people living with cystic fibrosis in Canada
- Epigenetic regulation and chromatin organization in cystic fibrosis airways
- Neuropsychiatric adverse effects following switch to vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: early experience from a regional centre
- Heterozygous CFTR variants associated with low-phospholipid-associated cholelithiasis phenotypes expand hepatobiliary disorders spectrum
- Extrapulmonary benefits and pharmacogenomics in lung transplant recipients with Cystic Fibrosis on Elexacaftor/Tezacaftor/Ivacaftor (ETI) therapy
- Vanzacaftor/tezacaftor/deutivacaftor partially restores CFTR function of the L467F;F508del complex allele in primary nasal epithelial cells
- Long-term outcomes of adolescents/adults with CF screen positive, inconclusive diagnosis
- Timeliness to diagnostic and early care milestones after newborn screening for Cystic Fibrosis in Texas: 14 years of experience at 2 centers
- Perspectives on inhaled medicines in the CFTR modulator era: A national survey of adults with cystic fibrosis
- Comfort discussing financial challenges and accessing resources in cystic fibrosis care among people with cystic fibrosis and their care partners: A cross-sectional survey study
- Basic science & translational research in cystic fibrosis – insights from the 20th ECFS basic science conference
- Model-informed dose reduction of elexacaftor/tezacaftor/ivacaftor therapy in adult people with cystic fibrosis: A simulation study
- Impaired insulin secretion in response to mixed meal ingestion is associated with hypersomatostatinemia in individuals with cystic fibrosis
- Distinct gastrointestinal symptom phenotypes in adults with cystic fibrosis are linked to complications and medication use: the GRAMPUS-CF study
- Impact of female CFTR variant carrier status on reproductive outcomes
- Evaluation of potential relationship between CFTR modulators, CFTR and neuropsychiatric symptoms in CF
- Rhabdomyolysis associated with piperacillin/tazobactam therapy: a case report
- Beyond lung function: the changing landscape of cystic fibrosis-related diabetes
- Continued burden of nontuberculous mycobacteria in the screened subpopulations of people with cystic fibrosis receiving CFTR modulator therapy
- Current knowledge, key gaps, and opportunities for future research on high-impact, modifiable lifestyle behaviors to promote healthy aging in adults with cystic fibrosis in the era of modulator therapy
- Airway microbial-inflammatory endotypes are associated with disease severity and predicted survival in cystic fibrosis
- Bacteriophage associated liver injury in a person with cystic fibrosis and prior liver transplantation
- Medication burden among adults with cystic fibrosis prescribed CFTR Modulators: a cross-sectional survey